What is the current market size?

The Sodium Citrate Blood Collection Tube market size was valued at USD 1.2 billion in 2023, driven by rising diagnostic testing demands and hospitalization rates.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2032, fueled by advancements in blood collection technologies and expanding healthcare infrastructure.

What are the primary growth drivers?

Key drivers include increased prevalence of chronic diseases, growing awareness of blood donation, and rising adoption of automated blood testing systems.

What challenges does the market face?

Challenges include stringent regulatory compliance, high production costs, and the need for sustainable packaging to meet environmental standards.

Which regions are leading the market?

North America and Europe dominate due to advanced healthcare systems, while Asia-Pacific shows high growth potential from expanding diagnostic facilities.

Who are the top companies in this market?

Leading players include BD, Terumo Corporation, and Medline Industries, leveraging innovation and strategic partnerships to maintain market dominance.

What are emerging opportunities?

Opportunities lie in point-of-care testing, home healthcare applications, and collaborations with government agencies to improve blood donation programs.

How is technology influencing the market?

Advancements like smart tubes with IoT-enabled data tracking and biodegradable materials are reshaping product development and patient safety standards.

What is the regulatory landscape like?

Regulatory bodies such as the FDA and ISO enforce strict quality and safety standards, requiring manufacturers to invest in compliance and R&D for market approval.

Sodium Citrate Blood Collection Tube Industry Size, Share & Growth Forecast 2033

Sodium Citrate Blood Collection Tube by Application (Hospital, Clinic, Research Institute, Others), by Types (3.2% Sodium Citrate, 3.8% Sodium Citrate, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 117

Forecast Period: 2026 - 2033

Market Size: $3500 million

CAGR: 5.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Sodium Citrate Blood Collection Tube Market Overview

The Sodium Citrate Blood Collection Tube market is a critical segment within the global healthcare diagnostics industry, offering anticoagulant solutions to prevent blood clotting during sample collection for coagulation testing. This market is essential for clinical laboratories, blood banks, and research facilities, where accurate and reliable sample preservation is vital for diagnostic outcomes. With the Sodium Citrate Blood Collection Tube market size projected to expand significantly, driven by rising demand in hospital diagnostics and advancements in point-of-care testing, the industry is poised for strategic growth. The market forecast for 2026–2033 highlights a compound annual growth rate (CAGR) of 5.8%, supported by macro drivers such as expanding healthcare infrastructure in emerging economies and increasing prevalence of cardiovascular diseases.

Loading chart…

Key forces shaping the Sodium Citrate Blood Collection Tube industry expansion include regulatory standardization of anticoagulant concentrations and technological innovations enhancing sample stability. Competitive intensity is rising as manufacturers prioritize R&D to develop eco-friendly packaging and automated filling systems. North America remains the largest region, accounting for over 40% of global revenue in 2025, while Asia-Pacific is the fastest-growing region, fueled by government investments in public healthcare and rising awareness about early disease detection. Strategic partnerships and geographic diversification by key players are critical to capitalizing on emerging opportunities in this dynamic market.

Report Overview

Report Attribute	Details
Market size value in 2025	3.50 billion
Revenue forecast in 2033	5.37 billion
Growth rate	CAGR of 5.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vitrex Medical; BD; CML Biotech; F.L. Medical; KS Medical; Medibrex; Improve Medical; Vacutest Kima; AB Medical; Beijing Hanbaihan Medical Devices; Jiangsu Kangyou Medical Instrument; Shenzhen Boomingshing Medical Device; Cardinal Health; Sarstedt; Avena Medica; BIOBASE; Paramedical Srl; Sanli Medical; Weihai Hongyu Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for anticoagulant tubes in diagnostic testing – The Sodium Citrate Blood Collection Tube market is poised for expansion due to increased adoption in coagulation diagnostics, particularly in trauma care and cardiovascular disease management. Regulatory endorsements for sodium citrate’s efficacy in preserving blood samples further validate its role in critical testing protocols.

Expansion of healthcare infrastructure in emerging economies – Rapid urbanization and government investments in diagnostic facilities across Asia-Pacific and Latin America are accelerating the Sodium Citrate Blood Collection Tube market size. These regions report higher unmet demand for standardized blood collection solutions, driving procurement by public and private healthcare providers.

Restraints2 items

Price sensitivity in price-competitive markets – Cost-conscious healthcare systems in Europe and North America favor cheaper alternatives like EDTA-based tubes, limiting the growth forecast for sodium citrate variants despite their specialized applications.

Stringent regulatory compliance costs – Manufacturers face elevated expenses in meeting ISO 15197 and CLIA standards for traceability and quality control, which disproportionately impacts smaller players in the Sodium Citrate Blood Collection Tube market.

Opportunities2 items

Integration with point-of-care testing (POCT) devices – Innovations in microfluidic POCT systems compatible with sodium citrate tubes open new revenue streams, particularly for emergency departments and rural clinics requiring rapid coagulation results.

Strategic partnerships with pharma and biotech firms – Collaborations to develop customized blood collection solutions for clinical trials and rare disease research are creating high-margin opportunities within the Sodium Citrate Blood Collection Tube market.

Challenges2 items

Supply chain volatility for citric acid feedstock – Geopolitical disruptions and reliance on China as a primary supplier of raw materials create pricing instability, squeezing profit margins for manufacturers.

Competition from synthetic anticoagulant alternatives – Emerging bioengineered anticoagulants with longer shelf lives threaten market share, compelling incumbents to invest in R&D to differentiate their sodium citrate offerings.

Market Segmentation

Loading chart…

The Sodium Citrate Blood Collection Tube segmentation by application reveals distinct market drivers. Diagnostic testing dominates, accounting for ~45% of demand, driven by rising hospitalization rates and chronic disease prevalence. Blood donation centers constitute ~30%, fueled by increased voluntary donations and plasma-derived pharmaceuticals. Research and biotechnology labs contribute ~25%, reflecting advancements in life sciences. These segments collectively define the market taxonomy, with diagnostic testing exhibiting the highest growth due to automation and POCT adoption.

By type, the market comprises Vacutainer Tubes (~60%) and Non-Vacutainer Tubes (~40%). Vacutainer Tubes include plastic (45%) and glass (15%) variants, preferred for standardized blood volume collection. Non-Vacutainer Tubes, such as manual draw systems, cater to specialized applications like coagulation testing. Plastic Vacutainer Tubes dominate due to cost efficiency and sterility, while glass variants maintain relevance in niche research settings requiring chemical inertness.

Sodium Citrate Blood Collection Tube Segmentation Breakdown9 items

Application

Hospital

Clinic

Research Institute

Others

Types

3.2% Sodium Citrate

3.8% Sodium Citrate

Others

Regional Insights

Loading chart…

North America dominates the Sodium Citrate Blood Collection Tube market growth, accounting for ~40% of global demand. Advanced healthcare infrastructure, high adoption of blood banking technologies, and robust R&D investments drive the region. Regulatory frameworks like CLIA standards ensure quality compliance, reinforcing market maturity. The aging population and rising chronic disease prevalence further fuel demand.

Europe holds ~30% market share, driven by stringent blood safety regulations, strong healthcare policies, and high adoption of automated blood collection systems. Germany and France lead due to advanced diagnostic ecosystems and cross-border collaborations in medical research. The region’s focus on regional forecast accuracy for blood product management sustains steady growth.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR exceeding 8% through 2030. Rising healthcare investments, urbanization, and improving diagnostic infrastructure in India and China underpin growth. Government initiatives to enhance blood donation programs and partnerships with global stakeholders are accelerating adoption.

Latin America (5%) and Middle East & Africa (5%) show gradual growth due to improving diagnostics infrastructure and public-private partnerships. Brazil and South Africa lead with initiatives to standardize blood collection protocols. However, underdeveloped healthcare systems in MEA remain a barrier, though regional investments are narrowing gaps.

Competitive Landscape

The Sodium Citrate Blood Collection Tube market is moderately consolidated, with a mix of global leaders and regional manufacturers competing on pricing, regulatory compliance, and product differentiation. Key players leverage Sodium Citrate Blood Collection Tube key players status through strategic partnerships, localized production, and certification portfolios to navigate fragmented regulatory environments. Competitive advantage is derived from rapid innovation in tube coatings, compatibility with diagnostic equipment, and cost-efficiency in bulk procurement. Distribution networks and OEM tie-ups remain critical for market access, particularly in emerging economies where local manufacturing reduces logistics costs.

Strategies among competitors emphasize product portfolio expansion, geographic diversification, and cost-optimization to offset margin pressures from commoditization. Differentiation hinges on proprietary anticoagulant formulations, customization for specialty tests, and compliance with ISO 15197 and CLSI standards. A key challenge is escalating compliance costs due to evolving IVD regulations, particularly in Europe and North America. Companies also face supply chain disruptions from raw material price volatility, prompting increased investment in regional supplier ecosystems.

BD: Premium pricing for integrated diagnostic solutions

Sarstedt: Vertical integration for cost control

Vitrex Medical: Regional expansion in Asia-Pacific

CML Biotech: OEM tie-ups for hospital-specific designs

KS Medical: R&D focus on trace element testing compatibility

Vacutest Kima: Localization through European manufacturing hubs

Key Sodium Citrate Blood Collection Tube Companies19 items

Vitrex Medical

CML Biotech

F.L. Medical

KS Medical

Medibrex

Improve Medical

Vacutest Kima

AB Medical

Beijing Hanbaihan Medical Devices

Jiangsu Kangyou Medical Instrument

Shenzhen Boomingshing Medical Device

Cardinal Health

Sarstedt

Avena Medica

BIOBASE

Paramedical Srl

Sanli Medical

Weihai Hongyu Medical Devices

Market Ecosystem

The Sodium Citrate Blood Collection Tube ecosystem spans upstream raw material sourcing, midstream manufacturing and integration, and downstream distribution to end users. Value is generated through the production of anticoagulant tubes optimized for blood sample preservation, with control points distributed across formulation, compliance, and logistics. Interactions between suppliers, producers, and healthcare systems define the value chain analysis for this specialized diagnostic market.

Raw material/component suppliers — Provide citric acid, glass/plastic tubing, and anticoagulant additives for production

OEM manufacturers — Produce sodium citrate tubes through molding, filling, and sterilization processes

Technology providers — Develop proprietary formulations for anticoagulant stability and hemolysis prevention

Distributors/channel partners — Manage regional logistics and inventory for healthcare facilities and labs

End users — Hospitals, reference labs, and point-of-care facilities utilizing tubes for coagulation testing

Regulators/standards bodies — Oversee compliance with ISO norms and FDA/EMA blood collection device guidelines

Waste management services — Handle biohazardous disposal of used collection tubes per regulatory protocols

Control points reside in regulatory approvals for formulation efficacy and raw material quality assurance. Dependency risks include supply chain volatility for specialty chemicals and compliance bottlenecks during product launches. End users face high switching costs due to standardized testing requirements and partnerships with certified distributors. Regional variations emerge in approval timelines and waste disposal infrastructure, affecting market access and operational costs.

Recent Industry Insights

The Sodium Citrate Blood Collection Tube industry has witnessed dynamic shifts over the past 18 months, driven by innovation and evolving healthcare demands. Strategic partnerships have emerged as a key growth lever, with manufacturers collaborating with global distributors to expand access to emerging markets, particularly in Asia-Pacific and Africa. Notably, a leading player recently acquired a niche lab equipment firm to strengthen its portfolio in anticoagulant solutions, reflecting a broader trend of mergers & acquisitions aimed at consolidating market share. Product/technology launches have accelerated, including eco-friendly tube designs and smart tubes with IoT-enabled tracking for improved inventory management. Regulatory bodies, such as the FDA and EU MDR, have introduced stricter guidelines on biocompatibility and traceability, prompting companies to invest in compliance upgrades. Meanwhile, the shift toward point-of-care testing and home diagnostics has spurred demand for compact, user-friendly collection systems. Funding activity remains robust, with startups securing Series B rounds to scale production of next-gen citrate-based tubes, positioning the Sodium Citrate Blood Collection Tube industry trends for sustained growth in 2024–2025.

Analyst Overview

The Sodium Citrate Blood Collection Tube market exhibits robust market attractiveness, driven by rising demand for diagnostic testing, blood donation programs, and advancements in healthcare infrastructure. With a long-term outlook shaped by aging populations and chronic disease prevalence, sustained growth is anticipated through 2030. However, competitive intensity remains moderate, characterized by established players leveraging R&D and strategic partnerships, while emerging firms challenge market share with cost-effective solutions. The innovation landscape is evolving, with focus on improving tube sterility, reducing sample contamination risks, and integrating smart labeling for traceability. Current demand–supply balance is stable, though supply chain disruptions and raw material price volatility pose short-term risks. Key risk factors include stringent regulatory compliance, regional healthcare budget constraints, and potential substitution by alternative anticoagulants. For stakeholders, navigating these dynamics while capitalizing on the Sodium Citrate Blood Collection Tube market outlook will be critical to securing a competitive edge.

12 items

1. Executive Summary

2. Sodium Citrate Blood Collection Tube Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Sodium Citrate Blood Collection Tube Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Sodium Citrate Blood Collection Tube Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Sodium Citrate Blood Collection Tube Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Sodium Citrate Blood Collection Tube Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Sodium Citrate Blood Collection Tube Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Sodium Citrate Blood Collection Tube Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Sodium Citrate Blood Collection Tube Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Sodium Citrate Blood Collection Tube Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Sodium Citrate Blood Collection Tube Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Sodium Citrate Blood Collection Tube Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Sodium Citrate Blood Collection Tube Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Sodium Citrate Blood Collection Tube Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Sodium Citrate Blood Collection Tube Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Sodium Citrate Blood Collection Tube Market Competition by Key Manufacturers

9.1. Global Sodium Citrate Blood Collection Tube Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Sodium Citrate Blood Collection Tube: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Vitrex Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. CML Biotech

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. F.L. Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. KS Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medibrex

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Improve Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Vacutest Kima

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. AB Medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Beijing Hanbaihan Medical Devices

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Jiangsu Kangyou Medical Instrument

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Shenzhen Boomingshing Medical Device

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Cardinal Health

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Sarstedt

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Avena Medica

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. BIOBASE

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Paramedical Srl

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Sanli Medical

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Weihai Hongyu Medical Devices

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Sodium Citrate Blood Collection Tube Market

Figure 4: Global Sodium Citrate Blood Collection Tube Market: Drivers

Figure 5: Global Sodium Citrate Blood Collection Tube Market: Challenges

Figure 6: Global Sodium Citrate Blood Collection Tube Market: Trends

Figure 7: Global Sodium Citrate Blood Collection Tube Market: Opportunity

Figure 8: Global Sodium Citrate Blood Collection Tube Market: Restraint

Figure 9: Global Sodium Citrate Blood Collection Tube Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Sodium Citrate Blood Collection Tube Market Value (USD Million) By Region

Figure 19: Global Sodium Citrate Blood Collection Tube Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Sodium Citrate Blood Collection Tube Market Value (USD Million) By Region

Figure 27: Global Sodium Citrate Blood Collection Tube Market Share (%) By: Regions (2032)

Figure 28: Global Sodium Citrate Blood Collection Tube Market Volume (K) By Region

Figure 29: Global Sodium Citrate Blood Collection Tube Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Sodium Citrate Blood Collection Tube Market Value (USD Million) By Region

Figure 37: Global Sodium Citrate Blood Collection Tube Market Share (%) By: Regions (2032)

Figure 38: Global Sodium Citrate Blood Collection Tube Market Volume (K) By Region

Figure 39: Global Sodium Citrate Blood Collection Tube Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

133 items

Table 1: Market Segmentation Analysis

Table 2: Global Sodium Citrate Blood Collection Tube Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Sodium Citrate Blood Collection Tube Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Sodium Citrate Blood Collection Tube Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Sodium Citrate Blood Collection Tube Market Value (USD Million) By Region

Table 14: Global Sodium Citrate Blood Collection Tube Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Sodium Citrate Blood Collection Tube Market Volume (K) By Region

Table 31: Global Sodium Citrate Blood Collection Tube Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Sodium Citrate Blood Collection Tube Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Sodium Citrate Blood Collection Tube Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Sodium Citrate Blood Collection Tube Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Vitrex Medical Basic Information And Sales Area

Table 52: Vitrex Medical. Products Portfolio

Table 53: BD Basic Information And Sales Area

Table 54: BD. Products Portfolio

Table 55: CML Biotech Basic Information And Sales Area

Table 56: CML Biotech. Products Portfolio

Table 57: F.L. Medical Basic Information And Sales Area

Table 58: F.L. Medical. Products Portfolio

Table 59: KS Medical Basic Information And Sales Area

Table 60: KS Medical. Products Portfolio

Table 61: Medibrex Basic Information And Sales Area

Table 62: Medibrex. Products Portfolio

Table 63: Improve Medical Basic Information And Sales Area

Table 64: Improve Medical. Products Portfolio

Table 65: Vacutest Kima Basic Information And Sales Area

Table 66: Vacutest Kima. Products Portfolio

Table 67: AB Medical Basic Information And Sales Area

Table 68: AB Medical. Products Portfolio

Table 69: Beijing Hanbaihan Medical Devices Basic Information And Sales Area

Table 70: Beijing Hanbaihan Medical Devices. Products Portfolio

Table 71: Jiangsu Kangyou Medical Instrument Basic Information And Sales Area

Table 72: Jiangsu Kangyou Medical Instrument. Products Portfolio

Table 73: Shenzhen Boomingshing Medical Device Basic Information And Sales Area

Table 74: Shenzhen Boomingshing Medical Device. Products Portfolio

Table 75: Cardinal Health Basic Information And Sales Area

Table 76: Cardinal Health. Products Portfolio

Table 77: Sarstedt Basic Information And Sales Area

Table 78: Sarstedt. Products Portfolio

Table 79: Avena Medica Basic Information And Sales Area

Table 80: Avena Medica. Products Portfolio

Table 81: BIOBASE Basic Information And Sales Area

Table 82: BIOBASE. Products Portfolio

Table 83: Paramedical Srl Basic Information And Sales Area

Table 84: Paramedical Srl. Products Portfolio

Table 85: Sanli Medical Basic Information And Sales Area

Table 86: Sanli Medical. Products Portfolio

Table 87: Weihai Hongyu Medical Devices Basic Information And Sales Area

Table 88: Weihai Hongyu Medical Devices. Products Portfolio

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Value (USD Million) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Market Volume (K) (2025-2032) By Types

Table 96: Global Market Share (%) By Types (2032)

Table 97: Global Sodium Citrate Blood Collection Tube Market Value (USD Million) By Region

Table 98: Global Sodium Citrate Blood Collection Tube Market Share (%) By Region (2025-2032)

Table 99: North America Market Value (USD Million) (2025-2032) By Country

Table 100: North America Market Value (USD Million) (2025-2032) By Application

Table 101: North America Market Value (USD Million) (2025-2032) By Types

Table 102: Europe Market Value (USD Million) (2025-2032) By Country

Table 103: Europe Market Value (USD Million) (2025-2032) By Application

Table 104: Europe Market Value (USD Million) (2025-2032) By Types

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 106: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 107: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 108: South America Market Value (USD Million) (2025-2032) By Country

Table 109: South America Market Value (USD Million) (2025-2032) By Application

Table 110: South America Market Value (USD Million) (2025-2032) By Types

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 112: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 113: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 114: Global Sodium Citrate Blood Collection Tube Market Volume (K) By Region

Table 115: Global Sodium Citrate Blood Collection Tube Market Share (%) By Region (2025-2032)

Table 116: North America Market Volume (K) (2025-2032) By Country

Table 117: North America Market Volume (K) (2025-2032) By Application

Table 118: North America Market Volume (K) (2025-2032) By Types

Table 119: Europe Market Volume (K) (2025-2032) By Country

Table 120: Europe Market Volume (K) (2025-2032) By Application

Table 121: Europe Market Volume (K) (2025-2032) By Types

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 123: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 124: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 125: South America Market Volume (K) (2025-2032) By Country

Table 126: South America Market Volume (K) (2025-2032) By Application

Table 127: South America Market Volume (K) (2025-2032) By Types

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 129: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 130: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 131: Research Programs/Design For This Report

Table 132: Key Data Information From Secondary Sources

Table 133: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Sodium Citrate Blood Collection Tube Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	3.50 billion
Revenue forecast in 2033	5.37 billion
Growth rate	CAGR of 5.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Vitrex Medical; BD; CML Biotech; F.L. Medical; KS Medical; Medibrex; Improve Medical; Vacutest Kima; AB Medical; Beijing Hanbaihan Medical Devices; Jiangsu Kangyou Medical Instrument; Shenzhen Boomingshing Medical Device; Cardinal Health; Sarstedt; Avena Medica; BIOBASE; Paramedical Srl; Sanli Medical; Weihai Hongyu Medical Devices
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Sodium Citrate Blood Collection Tube Segmentation Breakdown9 items

Application

Hospital

Clinic

Research Institute

Others

Types

3.2% Sodium Citrate

3.8% Sodium Citrate

Others

Regional Insights

Loading chart…

Competitive Landscape

BD: Premium pricing for integrated diagnostic solutions

Sarstedt: Vertical integration for cost control

Vitrex Medical: Regional expansion in Asia-Pacific

CML Biotech: OEM tie-ups for hospital-specific designs

KS Medical: R&D focus on trace element testing compatibility

Vacutest Kima: Localization through European manufacturing hubs

Key Sodium Citrate Blood Collection Tube Companies19 items

Vitrex Medical

CML Biotech

F.L. Medical

KS Medical

Medibrex

Improve Medical

Vacutest Kima

AB Medical

Beijing Hanbaihan Medical Devices

Jiangsu Kangyou Medical Instrument

Shenzhen Boomingshing Medical Device

Cardinal Health

Sarstedt

Avena Medica

BIOBASE

Paramedical Srl

Sanli Medical

Weihai Hongyu Medical Devices

Market Ecosystem

Raw material/component suppliers — Provide citric acid, glass/plastic tubing, and anticoagulant additives for production

OEM manufacturers — Produce sodium citrate tubes through molding, filling, and sterilization processes

Technology providers — Develop proprietary formulations for anticoagulant stability and hemolysis prevention

Distributors/channel partners — Manage regional logistics and inventory for healthcare facilities and labs

End users — Hospitals, reference labs, and point-of-care facilities utilizing tubes for coagulation testing

Regulators/standards bodies — Oversee compliance with ISO norms and FDA/EMA blood collection device guidelines

Waste management services — Handle biohazardous disposal of used collection tubes per regulatory protocols

Recent Industry Insights

Analyst Overview

Table of Contents